117 related articles for article (PubMed ID: 7379211)
1. Antimitotic activity of dehydroretronecine, a pyrrolizidine alkaloid metabolite, and some analogous compounds, in a rat liver parenchymal cell line.
Mattocks AR; Legg RF
Chem Biol Interact; 1980 Jun; 30(3):325-36. PubMed ID: 7379211
[TBL] [Abstract][Full Text] [Related]
2. The toxic effects in rats of some synthanecine carbamate and phosphate esters analogous to hepatotoxic pyrrolizidine alkaloids.
Driver HE; Mattocks AR
Chem Biol Interact; 1984 Sep; 51(2):201-18. PubMed ID: 6467455
[TBL] [Abstract][Full Text] [Related]
3. Carcinogenicity of some pyrrolic pyrrolizidine alkaloid metabolites and analogues.
Mattocks AR; Cabral JR
Cancer Lett; 1982 Oct; 17(1):61-6. PubMed ID: 6817913
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the pneumotoxicity of some pyrrolic esters and similar compounds analogous to pyrrolizidine alkaloid metabolites, given intravenously to rats.
Mattocks AR; Driver HE
Toxicology; 1983 Jun; 27(2):159-77. PubMed ID: 6612746
[TBL] [Abstract][Full Text] [Related]
5. Localization in the cell cycle of the antimitotic action of the pyrrolizidine alkaloid, lasiocarpine and of its metabolite, dehydroheliotridine.
Samuel A; Jago MV
Chem Biol Interact; 1975 Mar; 10(3):185-97. PubMed ID: 1126005
[TBL] [Abstract][Full Text] [Related]
6. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
Wang YP; Yan J; Fu PP; Chou MW
Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
[TBL] [Abstract][Full Text] [Related]
7. Evaluation in vitro of several pyrrolizidine alkaloid carcinogens: observations on the essential pyrrolic nucleus.
Styles J; Ashby J; Mattocks AR
Carcinogenesis; 1980 Feb; 1(2):161-4. PubMed ID: 22282996
[TBL] [Abstract][Full Text] [Related]
8. Metabolic activation of pyrrolizidine alkaloids by human, rat and avocado microsomes.
Couet CE; Hopley J; Hanley AB
Toxicon; 1996 Sep; 34(9):1058-61. PubMed ID: 8896199
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of different phases of the cell cycle to selected hepatotoxins in cultured liver-derived (BL9L) cells.
Skilleter DN; Mattocks AR; Neal GE
Xenobiotica; 1988 Jun; 18(6):699-705. PubMed ID: 3138828
[TBL] [Abstract][Full Text] [Related]
10. Dehydroretronecine-induced rhabdomyosarcomas in rats.
Allen JR; Hsu IC; Carstens LA
Cancer Res; 1975 Apr; 35(4):997-1002. PubMed ID: 1116156
[TBL] [Abstract][Full Text] [Related]
11. Liver cell enlargement in rats given hydroxymethyl pyrroles analogous to pyrrolizidine alkaloid metabolites, followed later by the hepatotoxin dimethylnitrosamine.
Mattocks AR
Toxicol Lett; 1981; 8(4-5):201-5. PubMed ID: 7268803
[TBL] [Abstract][Full Text] [Related]
12. Antimitotic effects of dehydroretronecine pyrrole.
Allen JR; Hsu IC
Proc Soc Exp Biol Med; 1974 Nov; 147(2):546-50. PubMed ID: 4548195
[No Abstract] [Full Text] [Related]
13. Detection of sulphur-conjugated pyrrolic metabolites in blood and fresh or fixed liver tissue from rats given a variety of toxic pyrrolizidine alkaloids.
Mattocks AR; Jukes R
Toxicol Lett; 1992 Oct; 63(1):47-55. PubMed ID: 1412522
[TBL] [Abstract][Full Text] [Related]
14. The comparative metabolism of the four pyrrolizidine alkaloids, seneciphylline, retrorsine, monocrotaline, and trichodesmine in the isolated, perfused rat liver.
Yan CC; Cooper RA; Huxtable RJ
Toxicol Appl Pharmacol; 1995 Aug; 133(2):277-84. PubMed ID: 7645024
[TBL] [Abstract][Full Text] [Related]
15. Hepato- and pneumotoxicity of pyrrolizidine alkaloids and derivatives in relation to molecular structure.
Culvenor CC; Edgar JA; Jago MV; Qutteridge A; Peterson JE; Smith LW
Chem Biol Interact; 1976 Mar; 12(3-4):299-324. PubMed ID: 1253333
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline.
Yan CC; Huxtable RJ
Toxicol Appl Pharmacol; 1994 Jul; 127(1):58-63. PubMed ID: 8048054
[TBL] [Abstract][Full Text] [Related]
17. Cytotoxicity of pyrrolizidine alkaloid in human hepatic parenchymal and sinusoidal endothelial cells: Firm evidence for the reactive metabolites mediated pyrrolizidine alkaloid-induced hepatotoxicity.
Yang M; Ruan J; Fu PP; Lin G
Chem Biol Interact; 2016 Jan; 243():119-26. PubMed ID: 26365561
[TBL] [Abstract][Full Text] [Related]
18. The effect of a pyrrolizidine alkaloid, monocrotaline, and a pyrrole, dehydroretronecine, on the biochemical functions of the pulmonary endothelium.
Huxtable R; Ciaramitaro D; Eisenstein D
Mol Pharmacol; 1978 Nov; 14(6):1189-203. PubMed ID: 732815
[No Abstract] [Full Text] [Related]
19. Chronic effects of monocrotaline pyrrole on hepatic mitosis and DNA synthesis.
Hsu IC; Chesney CF; Allen JR
Proc Soc Exp Biol Med; 1973 Apr; 142(4):1133-6. PubMed ID: 4694813
[No Abstract] [Full Text] [Related]
20. Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver.
Mattocks AR; Croswell S; Jukes R; Huxtable RJ
Toxicon; 1991; 29(4-5):409-15. PubMed ID: 1907409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
